Transcending Biotechnologies is categorized under Commercial Biotechnical Research in Houston, TX and active since 2001.
Transcending Biotechnologies was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Cheng Peng at the company’s single location by writing to 8032 El Rio St, Houston, Texas TX 77054 or by phoning (972) 239-2500. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Transcending Biotechnologies |
| Contact Person: | Cheng Peng |
| Address: | 8032 El Rio St, Houston, Texas 77054 |
| Phone Number: | (972) 239-2500 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Transcending Biotechnologies was started in 2001 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Cheng Peng for inquiries that concern Transcending Biotechnologies by calling the company number (972) 239-2500, as your correspondence is most welcome. Additionally, the physical location of the single location of Transcending Biotechnologies can be found at the coordinates as well as the street address 8032 El Rio St in Houston, Texas 77054.
For its online presence, you may visit Transcending Biotechnologies’s website at and engage with its social media outlets through on Twitter and on Facebook.